
Sep 29, 2026 · 7 min
Policy shift puts FICO’s credit-score dominance at risk
Piper Sandler Drops, Summit Therapeutics Jumps, Fair Isaac Sinks as New Policy Seen Spurring Competition
The episode links three sharp stock moves to a possible investment-bank combination, a major biotech deal, and rising competition in credit scoring.
- 1Piper Sandler shares fall as the firm explores a possible combination with Perella Weinberg Partners.
- 2Summit Therapeutics rallies after AstraZeneca commits $2 billion to collaborate on its cancer drug candidate ivonescimab.
- 3Fair Isaac plunges as a policy proposal could make VantageScore easier for lenders to adopt.
Don't miss
Fair Isaac shares plunge after a policy proposal could make it easier for lenders to adopt VantageScore.
The brief
Piper Sandler shares decline as the firm discusses a possible combination with Perella Weinberg Partners, whose M&A capabilities could complement Piper Sandler’s business.
Summit Therapeutics moves sharply higher after AstraZeneca agrees to invest $2 billion and collaborate on ivonescimab, its cancer drug candidate.
The episode’s clearest market tension arrives with Fair Isaac: a policy proposal could make VantageScore easier for lenders to use, intensifying competition for FICO.
Together, the moves show how corporate deal talks, pharmaceutical investment, and regulatory changes can quickly reshape expectations for individual companies.
What was said on this episode
2 statements · 2 positive
Perella Weinberg’s M&A advisors would complement Piper Sandler’s capabilities.
“I think this For Sandler, I think this would be a great deal because they have some capital markets, some good capital markets capabilities. They have some industry expertise, healthcare for example. But boy, the powerful, uh, M&A advisors at Perella Weinberg I think would be a nice fit.”
Listen at 1:26
The AstraZeneca investment is beneficial for Summit Therapeutics.
“So certainly a good move for Summit Therapeutics.”
Listen at 2:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Listen to the full episode and explore every guest, topic, and moment on PodLume.

Piper Sandler
Perella Weinberg Partners
Fair Isaac